Latest Observability News

Piche Resources has received formal environmental approval to begin its maiden drilling campaign at the Cerro Chacon gold-silver project in Argentina, targeting a 14 km mineralised corridor with 57 planned drill holes.

Barton Gold Holdings has raised $3 million through a premium-priced placement to fast-track resource upgrade drilling at its Tunkillia Gold Project, boosting its cash reserves to $9 million with minimal dilution.

Dateline Resources reports promising geochemical anomalies at its Colosseum Gold-REE Project in California, hinting at extensions to the known gold mineralisation and reinforcing rare earth element prospects.

Vulcan Energy has begun drilling the first new well for its Phase One Lionheart Project in Germany, marking a critical step toward expanding its renewable geothermal energy and lithium production capacity.

OncoSil Medical has secured $8.7 million through a placement and share purchase plan to fund commercialization of its pancreatic cancer treatment device, aiming for positive cash flow by mid-2026. Near-completion clinical trials could soon unlock broader market access.

Mt Malcolm Mines reports promising drilling results at Golden Crown and prepares for an infill program at Dumbarton, aiming to establish maiden resource estimates and advance towards production.

Viva Leisure has taken a strategic 33% stake in Gorilla X Labs, aiming to deepen its footprint in the sports nutrition market and enhance member offerings across its platforms.

Nimy Resources has identified a new outcropping chlorite schist 480 metres east of its initial gallium discovery at Block 3, prompting an accelerated drilling program to explore this promising extension.

WiseTech Global has announced a $2.1 billion acquisition of US-based e2open, aiming to create a comprehensive global trade and logistics marketplace. The deal, fully debt-funded and expected to close in the first half of 2026, promises to expand WiseTech’s product suite, customer base, and market reach.

Focus Minerals has agreed to sell its Laverton Gold Project to Genesis Minerals for A$250 million in cash, aiming to boost shareholder value and fund ongoing operations.

Immutep’s novel immunotherapy combination with radiotherapy and KEYTRUDA® has met its primary endpoint in a Phase II trial for resectable soft tissue sarcoma, showing promising early signs of improved patient outcomes.

Lykos Metals announces key leadership changes with David Wheeler stepping up as Non-Executive Chair and Petar Tomasevic taking the helm as Interim CEO, signaling a strategic pivot as the company advances in the Balkan region.